2183.T

Linical Co., Ltd. [2183.T] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

2183.T Stock Summary

Top 2183.T Correlated Resources

2183.T

Top 10 Correlated ETFs

2183.T

Top 10 Correlated Stocks

2183.T

In the News

2183.T Financial details

Company Rating
-
Market Cap
8.79B
Income
680.4M
Revenue
12.52B
Book val./share
-
Cash/share
-
Dividend
14
Dividend %
2.58%
Employees
759
Optionable
No
Shortable
Yes
Earnings
14 Feb 2024
P/E
17.17
Forward P/E
-
PEG
-12.31
P/S
0.97
P/B
1.54
P/C
-
P/FCF
-
Quick Ratio
0.99
Current Ratio
1.69
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
30.12
EPS next Y
-
EPS next Q
-
EPS this Y
27.06%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.13%
Revenue last 5Y
2.04%
Revenue Q/Q
6.77%
EPS Q/Q
-57.47%
-
-
-
-
SMA20
-9.48%
SMA50
-14.28%
SMA100
-13.67%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
9%
ROC
0.12%
Gross Margin
34%
Oper. Margin
10%
Profit Margin
6%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
374.0-874.0
52W High
-66.02%
52W Low
-20.59%
RSI
45.52
Rel Volume
0.16
Avg Volume
95.79K
Volume
15.8K
Perf Week
0.34%
Perf Month
-12.39%
Perf Quarter
-17.96%
Perf Half Y
-19.73%
-
-
-
-
Beta
0.262
-
-
Volatility
1.18%, 21.26%
Prev Close
0.34%
Price
297
Change
0.34%

2183.T Financial Performance

2183.T Dividend History

2183.T Frequently Asked Questions

What is Linical Co., Ltd. stock symbol ?

Linical Co., Ltd. is a JP stock and trading under the symbol 2183.T

What is Linical Co., Ltd. stock quote today ?

Linical Co., Ltd. stock price is $297 today.

Is Linical Co., Ltd. stock public?

Yes, Linical Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
1YD.DE
MIX.JO
MSF.DE
FB2A.DE
BRYN.DE
Top Correlated ETFs
ROBO
FTSL
DBB
DXJ
REMX
Top Correlated Stocks
4064.T
4092.T
4208.T
4246.T
4471.T
Similar Market Cap
603680.SS
ESI
HESTERBIO.NS
2852.TW
LY0.DE

Company Profile

Healthcare Biotechnology
  • Volume Average 95.79K
  • Market Capitalization 8.79B
  • Employee 759
  • CEO Mr. Kazuhiro Hatano
  • Headquarters Osaka,JP
  • IPO Date 2008-10-27
  • Website https://www.linical.co.jp

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariat; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.